On June 8, 2007, a Notice of Violation was issued for two Severity Level III violations. The first violation involved a failure to verify that a high dose rate remote afterloader brachytherapy treatment was administered in accordance with the treatment plan and written directive. The second violation involved a failure to report a medical event. Specifically, a high dose rate remote afterloader treatment fraction was delivered in which the source was positioned outside of the patient's body for a portion of the treatment. The dose delivered to the treatment site differed from the prescribed dose by more than 50 rem to an organ or tissue and the fractionated dose differed from the prescribed dose, for a single fraction, by 50 percent or more.